Back to Search
Start Over
Colorectal cancer-associated microbiota contributes to oncogenic epigenetic signatures.
- Source :
-
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2019 Nov 26; Vol. 116 (48), pp. 24285-24295. Date of Electronic Publication: 2019 Nov 11. - Publication Year :
- 2019
-
Abstract
- Sporadic colorectal cancer (CRC) is a result of complex interactions between the host and its environment. Environmental stressors act by causing host cell DNA alterations implicated in the onset of cancer. Here we investigate the stressor ability of CRC-associated gut dysbiosis as causal agent of host DNA alterations. The epigenetic nature of these alterations was investigated in humans and in mice. Germ-free mice receiving fecal samples from subjects with normal colonoscopy or from CRC patients were monitored for 7 or 14 wk. Aberrant crypt foci, luminal microbiota, and DNA alterations (colonic exome sequencing and methylation patterns) were monitored following human feces transfer. CRC-associated microbiota induced higher numbers of hypermethylated genes in murine colonic mucosa (vs. healthy controls' microbiota recipients). Several gene promoters including SFRP1,2,3, PENK, NPY, ALX4, SEPT9, and WIF1 promoters were found hypermethylated in CRC but not in normal tissues or effluents from fecal donors. In a pilot study ( n = 266), the blood methylation levels of 3 genes ( Wif1 , PENK , and NPY ) were shown closely associated with CRC dysbiosis. In a validation study ( n = 1,000), the cumulative methylation index (CMI) of these genes was significantly higher in CRCs than in controls. Further, CMI appeared as an independent risk factor for CRC diagnosis as shown by multivariate analysis that included fecal immunochemical blood test. Consequently, fecal bacterial species in individuals with higher CMI in blood were identified by whole metagenomic analysis. Thus, CRC-related dysbiosis induces methylation of host genes, and corresponding CMIs together with associated bacteria are potential biomarkers for CRC.<br />Competing Interests: Competing interest statement: I.S. shares rights in 3 patents: EP B31120, EP2635705, and EP 2955232 A1 20151216 based on methods for diagnosing adenomas and/or colorectal cancer.
- Subjects :
- Animals
Cohort Studies
DNA Methylation
Dysbiosis genetics
Dysbiosis microbiology
Dysbiosis pathology
Fecal Microbiota Transplantation
Feces microbiology
Female
Gene Expression Regulation
Germ-Free Life
Humans
Intestinal Mucosa metabolism
Intestinal Mucosa pathology
Male
Mice, Inbred C3H
Promoter Regions, Genetic
RNA, Ribosomal, 16S
Colorectal Neoplasms genetics
Colorectal Neoplasms microbiology
Epigenesis, Genetic
Gastrointestinal Microbiome genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1091-6490
- Volume :
- 116
- Issue :
- 48
- Database :
- MEDLINE
- Journal :
- Proceedings of the National Academy of Sciences of the United States of America
- Publication Type :
- Academic Journal
- Accession number :
- 31712445
- Full Text :
- https://doi.org/10.1073/pnas.1912129116